NeuroCult™-XF Proliferation Medium

Xeno-free medium for expansion of human neural stem and progenitor cells
NeuroCult™-XF Proliferation Medium

Xeno-free medium for expansion of human neural stem and progenitor cells

1 Kit
Catalog # 05761
321 USD
Required Products
  1. Heparin Solution
    Heparin Solution

    Cell culture supplement

  2. Human Recombinant bFGF
    Human Recombinant bFGF

    Basic fibroblast growth factor

  3. Human Recombinant EGF
    Human Recombinant EGF

    Epidermal growth factor

Overview

NeuroCult™-XF Proliferation Medium is a standardized, xeno-free, serum-free medium for the culture of human neural stem and progenitor cells from normal tissues or tumor samples, in the neurosphere or adherent monolayer system. When supplemented with appropriate cytokines, NeuroCult™-XF Proliferation Medium is optimized to maintain human neural stem cells in culture for extended periods of time without the loss of their self-renewal, proliferation or differentiation potential.

NOTE: Addition of Carrier-Free rh EGF (Catalog #78006) and rh bFGF (Catalog #78003) is required. Heparin (Catalog #07980) can also be added, however, the heparin solution contains non-human animal-derived components and can be omitted if a complete xeno-free system is desired.
Components
  • NeuroCult™-XF Basal Medium, 450 mL
  • NeuroCult™-XF Proliferation Supplement, 50 mL
Subtype
Specialized Media
Cell Type
Brain Tumor Stem Cells, Neural Stem and Progenitor Cells
Species
Human
Application
Cell Culture, Colony Assay, Expansion, Functional Assay, Spheroid Culture
Brand
NeuroCult
Area of Interest
Cancer, Disease Modeling, Drug Discovery and Toxicity Testing, Neuroscience, Stem Cell Biology, Transplantation Research
Formulation
Serum-Free, Xeno-Free

Scientific Resources

Product Documentation

Document Type Product Name Catalog # Lot # Language
Document Type
Product Information Sheet
Product Name
NeuroCult™-XF Proliferation Medium
Catalog #
05761
Lot #
All
Language
English
Document Type
Manual
Product Name
NeuroCult™-XF Proliferation Medium
Catalog #
05761
Lot #
All
Language
English
Document Type
Safety Data Sheet 1
Product Name
NeuroCult™-XF Proliferation Medium
Catalog #
05761
Lot #
All
Language
English
Document Type
Safety Data Sheet 2
Product Name
NeuroCult™-XF Proliferation Medium
Catalog #
05761
Lot #
All
Language
English

Educational Materials (11)

Brochure
NeuroCult™: Reagents for Brain Tumor Stem Cell Research
Brochure
Tools for Cancer Research
Brochure
NeuroCult™-XF: Xeno-Free Culture Medium for the Proliferation of Human Neural Stem Cells
Protocol
How to Cryopreserve Neurospheres
Wallchart
Neural Stem Cells
Wallchart
SnapShot: The Intestinal Crypt
Video
NeuroCult™ Proliferation Media
1:58
NeuroCult™ Proliferation Media
Webinar
Standardized Media and Reagents for Neural Stem Cell Research with NeuroCult™
41:19
Standardized Media and Reagents for Neural Stem Cell Research with NeuroCult™
Webinar
Neural Stem Cell Culture Systems - Neurosphere vs. Adherent Monolayer Culture
47:21
Neural Stem Cell Culture Systems - Neurosphere vs. Adherent Monolayer Culture
Webinar
Identification and Characterization of Neural Stem Cells: Why is This so Darned Difficult?
1:06:37
Identification and Characterization of Neural Stem Cells: Why is This so Darned Difficult?
Mini Review
Neural Stem Cells: Identification, Function, Culture, and Isolation

Product Applications

This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.

Data and Publications

Data

NSCs cultured in NeuroCult™-ACF Proliferation Medium maintain multi-lineage potential in long-term cultures

Figure 1. Neurospheres Derived from Human Fetal CNS Tissue can be Efficiently Generated for Multiple Passages in NeuroCult™-XF Proliferation Medium (n = 3)

Total cell expansion obtained with NeuroCult™-XF is comparable to that obtained with NeuroCult™ NS-A Proliferation Medium (Human).

Neurospheres derived from human fetal CNS tissue can be efficiently generated for multiple passages in NeuroCult™-ACF Proliferation Medium

Figure 2. NSCs Cultured in NeuroCult™-XF Proliferation Medium Maintain Multi-Lineage Differentiation Potential in Long-Term Cultures

The graph indicates the percentage of neurons (class III ß-tubulin-positive), astrocytes (GFAP-positive) and oligodendrocytes (O4-positive) generated following differentiation of NSCs previously cultured in NeuroCult™-XF or NeuroCult™ NS-A Proliferation Medium (Human). The differentiation potential of NSCs cultured in NeuroCult™-XF is comparable to NSCs cultured in NeuroCult™ NS-A Proliferation Medium (Human).

Publications (3)

Bulletin of experimental biology and medicine 2015 AUG The Use of Autologous Mesenchymal Stem Cells for Cell Therapy of Patients with Amyotrophic Lateral Sclerosis in Belarus. Rushkevich YN et al.

Abstract

We studied a new method of treatment of amyotrophic lateral sclerosis with autologous mesenchymal stem cells. Autologous mesenchymal stem cells were injected intravenously (intact cells) or via lumbar puncture (cells committed to neuronal differentiation). Evaluation of the results of cell therapy after 12-month follow-up revealed slowing down of the disease progression in 10 patients in comparison with the control group consisting of 15 patients. The cell therapy was safe for the patients.
Annals of translational medicine 2014 OCT Chemically defined serum-free and xeno-free media for multiple cell lineages. Usta S et al.

Abstract

Cell culture is one of the most common methods used to recapitulate a human disease environment in a laboratory setting. Cell culture techniques are used to grow and maintain cells of various types including those derived from primary tissues, such as stem cells and cancer tumors. However, a major confounding factor with cell culture is the use of serum and animal (xeno) products in the media. The addition of animal products introduces batch and lot variations that lead to experimental variability, confounds studies with therapeutic outcomes for cultured cells, and represents a major cost associated with cell culture. Here we report a commercially available serum-free, albumin-free, and xeno free (XF) media (Neuro-Pure(TM)) that is more cost-effective than other commercial medias. Neuro-Pure was used to maintain and differentiate various cells of neuronal lineages, fibroblasts, as well as specific cancer cell lines; without the use of contaminants such serum, albumin, and animal products. Neuro-Pure allows for a controlled and reproducible cell culture environment that is applicable to translational medicine and general tissue culture.
Proceedings of the National Academy of Sciences 2013 APR Hypoxia induces a phase transition within a kinase signaling network in cancer cells Wei W et al.

Abstract

Hypoxia is a near-universal feature of cancer, promoting glycolysis, cellular proliferation, and angiogenesis. The molecular mechanisms of hypoxic signaling have been intensively studied, but the impact of changes in oxygen partial pressure (pO2) on the state of signaling networks is less clear. In a glioblastoma multiforme (GBM) cancer cell model, we examined the response of signaling networks to targeted pathway inhibition between 21% and 1% pO2. We used a microchip technology that facilitates quantification of a panel of functional proteins from statistical numbers of single cells. We find that near 1.5% pO2, the signaling network associated with mammalian target of rapamycin (mTOR) complex 1 (mTORC1)--a critical component of hypoxic signaling and a compelling cancer drug target--is deregulated in a manner such that it will be unresponsive to mTOR kinase inhibitors near 1.5% pO2, but will respond at higher or lower pO2 values. These predictions were validated through experiments on bulk GBM cell line cultures and on neurosphere cultures of a human-origin GBM xenograft tumor. We attempt to understand this behavior through the use of a quantitative version of Le Chatelier's principle, as well as through a steady-state kinetic model of protein interactions, both of which indicate that hypoxia can influence mTORC1 signaling as a switch. The Le Chatelier approach also indicates that this switch may be thought of as a type of phase transition. Our analysis indicates that certain biologically complex cell behaviors may be understood using fundamental, thermodynamics-motivated principles.
View All Publications

Contact STEMCELL Technologies

Our Customer Service, Sales, and Product and Scientific Support departments in North America are available between 6 am and 5 pm Pacific Time (9 am and 8 pm Eastern Time). One of our representatives will be happy to help you by telephone or email. Please complete the form to contact us by email. A representative will get back to you shortly.
  •  

StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not share your email address with third parties. StemCell Technologies Inc. will use your email address to confirm your identity and send you newsletters, transaction-related emails, promotional and customer service emails in accordance with our privacy policy. You can change your email preferences at any time.